NEW YORK April 12 2017 PRNewswire Immune Pharmaceuticals Inc. Nasdaq IMNP "Immune" or the "Company" today announced a reverse stock split of its shares of common stock at a ratio of 1for20. Beginning with the opening of trading on Apri...
↧